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General Procedure A. The appropriate pyridine N-oxide (1.0 equiv) and 4-nitrobenzoyl chloride 
(2.2 equiv) were added to a 20 mL flame-dried microwave vial. The pressure was carefully restored using 
a nitrogen/argon balloon. The appropriate cyclic thioether (0.2 M) was introduced, and the mixture cooled 
to 0 °C. Triethylamine (2.2 equiv) was added, with rapid stirring of the reaction mixture. Following com-
pletion of addition, the cooling bath was removed and the mixture stirred for 5 minutes at room tempera-
ture before heating to 50 °C overnight. Ethyl acetate (EtOAc) (5 mL) was added, the mixture transferred 
to a round-bottomed flask and the volatiles were removed under reduced pressure. Compounds were pu-
rified by flash column chromatography, eluting with the stated solvent systems. 
General Procedure B. The appropriate pyridine N-oxide (1.0 equiv) and 4-nitrobenzoyl chloride 
(2.2 equiv) were added to a 20 mL flame-dried microwave vial. The pressure was carefully restored using 
a nitrogen/argon balloon. Diisopropyl ether (0.4 M) and the appropriate cyclic thioether (5.0 equiv) were 
introduced, and the mixture cooled to 0 °C. Triethylamine (2.2 equiv) was added, with rapid stirring of 
 the reaction mixture. Following completion of addition, the cooling bath was removed and the mixture 
stirred for 5 minutes at room temperature before heating to 50 °C overnight. EtOAc (5 mL) was added, 
the mixture transferred to a round-bottomed flask and the volatiles were removed under reduced pressure. 
Compounds were purified by flash column chromatography, eluting with the stated solvent systems. 
2-((4-Chlorobutyl)thio)nicotinonitrile (4a). Following General Procedure A, 3-cyanopyridine N-oxide 
(100 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) in tetrahydrothiophene (THT) 
(0.2 M), after purification via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 
isocratic), afforded the title compound 4a (138 mg, 0.61 mmol, 74%) as a yellow oil. IR (ATR)/cm-1 3061, 
2936, 2864, 2222, 1571, 1549, 1443, 1391; 1H NMR (400 MHz, CDCl3įGGJ = 4.9 Hz, J = 1.8 
Hz, 1H), 7.79 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.07 (dd, J = 7.7 Hz, J = 4.9 Hz, 1H), 3.58 (t, J = 6.3 Hz, 
2H), 3.31 (t, J = 6.9 Hz, 2H), 1.99±1.86 (m, 4H); 13C NMR (101 MHz, CDCl3į
118.6, 115.6, 107.7, 44.5, 31.6, 29.4, 26.6; LRMS (ES + APCI) m/z: calcd. for C10H1135ClN2S 226.0; 
found 227.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C10H1235ClN2S 227.0410; found 
227.0408. 
2-((4-Chlorobutyl)thio)isonicotinonitrile (4b). Following General Procedure A, 4-cyanopyridine N-oxide 
(100 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) in THT (0.2 M), after purification 
via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 isocratic), afforded the ti-
tle compound 4b (52 mg, 0.23 mmol, 28%) as a yellow oil. IR (ATR)/cm-1 3050, 2925, 2853, 2237, 1584, 
1530, 1458, 1365; 1H NMR (400 MHz, CDCl3įGJ = 5.1 Hz, 1H), 7.38±7.36 (m, 1H), 7.15 (dd, 
J = 5.1 Hz, J = 1.4 Hz, 1H), 3.57 (t, J = 6.3 Hz, 2H), 3.22 (t, J = 7.0 Hz, 2H), 1.97±1.83 (m, 4H); 13C 
NMR (101 MHz, CDCl3į 161.5, 150.3, 124.0, 120.4, 120.0, 116.4, 44.5, 31.6, 29.3, 26.7; LRMS (ES + 
APCI) m/z: calcd. for C10H1135ClN2S 226.0; found 226.9 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. 
for C10H1235ClN2S 227.0410; found 227.0406. 
3-Chloro-2-((4-chlorobutyl)thio)pyridine (4c). Following General Procedure A, 3-chloropyridine N-oxide 
(108 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) in THT (0.2 M), after purification 
 via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 isocratic), afforded the ti-
tle compound 4c (100 mg, 0.42 mmol, 51%) as a yellow oil. IR (ATR)/cm-1 3044, 2929, 2864, 1566, 1434, 
1387; 1H NMR (400 MHz, CDCl3įGGJ = 4.7 Hz, J = 1.5 Hz, 1H), 7.53 (dd, J = 7.8 Hz, J = 1.5 
Hz, 1H), 6.95 (dd, J = 7.8 Hz, J = 4.7 Hz, 1H), 3.58 (t, J = 7.0 Hz, 2H), 3.23 (t, J = 7.0 Hz, 2H), 1.99±
1.84 (m, 4H); 13C NMR (101 MHz, CDCl3į
LRMS (ES + APCI) m/z: calcd. for C9H1135Cl2NS 235.0; found 235.9 [M+H]+; HRMS (ESI, +ve) m/z: 
[M+H]+ calcd. for C9H1235Cl2NS 236.0067; found 236.0063. 
4-Chloro-2-((4-chlorobutyl)thio)pyridine (4d). Following General Procedure A, 4-chloropyridine N-ox-
ide (107.5 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) in THT (0.2 M), after puri-
fication via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 isocratic), afforded 
the title compound 4d (77 mg, 0.33 mmol, 39%) as a yellow oil. IR (ATR)/cm-1 3042, 2933, 2864, 1562, 
1540, 1452, 1355; 1H NMR (400 MHz, CDCl3įGJ = 5.4 Hz, 1H), 7.18±7.16 (m, 1H), 6.97 (dd, 
J = 5.4 Hz, J = 1.9 Hz, 1H), 3.57 (t, J = 7.0 Hz, 2H), 3.20 (t, J = 7.0 Hz, 2H), 1.97±1.82 (m, 4H); 13C 
NMR (101 MHz, CDCl3įLRMS (ES + APCI) 
m/z: calcd. for C9H1135Cl2NS 235.0; found 235.9 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C9H1235Cl2NS 236.0067; found 236.0063. 
2-((4-Chlorobutyl)thio)-3-nitropyridine (4e). Following General Procedure A, 3-nitropyridine N-oxide 
(116 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) in THT (0.2 M), after purification 
via flash column chromatography (dry loading, petroleum ether/EtOAc 8:1 isocratic), afforded the ti-
tle compound 4e (75 mg, 0.30 mmol, 37%) as a yellow oil. IR (ATR)/cm-1 3076, 2931, 2860, 1584, 1554, 
1510, 1396, 1329; 1H NMR (400 MHz, CDCl3įGGJ = 4.6 Hz, J = 1.7 Hz, 1H), 8.48 (dd, J = 8.2 
Hz, J = 1.7 Hz, 1H), 7.19 (dd, J = 8.2 Hz, J = 4.6 Hz, 1H), 3.59 (t, J = 7.0 Hz, 2H), 3.26 (t, J = 7.0 Hz, 
2H), 2.01±1.85 (m, 4H); 13C NMR (101 MHz, CDCl3)  158.1, 153.2, 142.3, 133.9, 118.7, 44.6, 31.9, 29.8, 
26.2; LRMS (ES + APCI) m/z: calcd. for C9H1135ClN2O2S 246.0; found 246.9 [M+H]+; HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C9H1235ClN2O2S 247.0308; found 247.0310. 
 5-Cyano-2-(trifluoromethyl)pyridine 1-oxide (1g).19 To a stirred mixture of 6-(trifluoromethyl)nicotinoni-
trile (1.00 g, 5.81 mmol) and urea-hydrogen peroxide addition complex (UHP) (1.15 g, 12.21 mmol) in 
CH2Cl2 (15 mL) was added trifluoroacetic anhydride (TFAA) (1.7 mL, 12.21 mmol) at 0 °C under argon. 
The reaction was allowed to stir at room temperature for 0.5 h. Excess peroxide was destroyed by the 
addition of 10% aqueous potassium iodide solution (50 mL). The organic phase was washed with satu-
rated 10% aqueous Na2S2O3 solution (50 mL) and water (50 mL), then dried over MgSO4, and filtered. 
The filtrate was concentrated under reduced pressure before the residue was triturated by diethyl ether to 
afford the title compound 1g as an off-white solid (571 mg, 3.04 mmol, 52%). m.p. 94±96 °C; IR 
(ATR)/cm-1 3031, 2988, 2243, 1605, 1549, 1389, 1277, 1155; 1H NMR (500 MHz, CDCl3įEUV
1H), 7.80 (d, J = 8.5 Hz, 1H), 7.53 (d, J = 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) į
125.9±125.8 (m, 1C), 122.6, 119.2 (q, JFC = 271.6 Hz), 115.8, 113.1; 19F NMR (471 MHz, CDCl3į-
69.6 (s, 3F); LRMS (ES + APCI) m/z: calcd. for C7H3F3N2O 188.0; found 187.1 [M±H]+; HRMS (ESI-
TOF) m/z: [M+H]+ calcd. for C7H4F3N2O 189.0276; found 189.0274. 
2-((4-Chlorobutyl)thio)-6-(trifluoromethyl)nicotinonitrile (4g). Following General Procedure A, com-
pound 1g (100 mg, 0.53 mmol) and 4-nitrobenzoyl chloride (218 mg, 1.17 mmol) in THT (0.2 M), after 
purification via flash column chromatography (dry loading, petroleum ether/CH2Cl2 3:1 isocratic), af-
forded the title compound 4g (94 mg, 0.32 mmol, 60%) as a yellow oil. IR (ATR)/cm-1 3079, 2940, 2869, 
2230, 1579, 1361, 1333, 1143; 1H NMR (500 MHz, CDCl3įGJ = 7.5 Hz, 1H), 7.42 (d, J = 7.5 
Hz, 1H), 3.58 (t, J = 6.5 Hz, 2H), 3.33 (t, J = 6.5 Hz, 2H), 1.98±1.89 (m, 4H); 13C NMR (125 MHz, 
CDCl3įTJFC = 36.1 Hz, 1C), 142.3, 120.7 (q, JFC = 273.9 Hz, 1C), 115.1 (q, JFC = 2.8 
Hz, 1C), 114.5, 110.4, 44.3, 31.6, 29.9, 26.5; 19F NMR (471 MHz, CDCl3 į -69.1 (s, 3F); LRMS 
(ES + APCI) m/z: calcd. for C11H1035ClF3N2S 294.0; found 295.0 [M+H]+; HRMS (ESI-TOF) m/z: 
[M+H]+ calcd. for C11H1135ClF3N2S 295.0284; found 295.0280. 
 2-((3-Cyanopyridin-2-yl)thio)cyclohexyl 4-nitrobenzoate (3j). Following General Procedure B, 3-cyano-
pyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) and 7-thiabicy-
clo[4.1.0]heptane (476 mg, 4.17 mmol) in diisopropyl ether (0.4 M), after purification via flash column 
chromatography (dry loading, petroleum ether/EtOAc 5:1 isocratic), afforded the title compound 3j (182 
mg, 0.48 mmol, 57%) as a yellow oil. IR (ATR)/cm-1 3050, 2933, 2856, 2224, 1720, 1571, 1525, 1391, 
1346, 1264; 1H NMR (500 MHz, CDCl3įGGJ = 5.0 Hz, J = 1.5 Hz, 1H), 8.18 (d, J = 9.0 Hz, 2H), 
8.03 (d, J = 9.0 Hz, 2H), 7.73 (dd, J = 8.0 Hz, J = 1.5 Hz, 1H), 7.08 (dd, J = 8.0 Hz, J = 5.0 Hz, 1H), 5.19 
(td, J = 9.0 Hz, J = 4.0 Hz, 1H), 4.43 (td, J = 9.0 Hz, J = 4.0 Hz, 1H), 2.37±2.23 (m, 2H), 1.90±1.66 (m, 
4H), 1.61±1.51 (m, 2H); 13C NMR (125 MHz, CDCl3į
123.5, 119.0, 115.4, 108.1, 77.4, 75.9, 46.5, 31.3, 25.1, 23.4; LRMS (ES + APCI) m/z: calcd. for 
C19H17N3O4S 383.1; found 384.2 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C19H18N3O4S 
384.1018; found 384.1019. 
2-((3-Cyanopyridin-2-yl)thio)ethyl 4-nitrobenzoate (3k). Following General Procedure B, with stirring at 
25 °C overnight 3-cyanopyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 
mmol) and thiirane (250 mg, 4.15 mmol) in diisopropyl ether (0.4 M), after purification via flash column 
chromatography (dry loading, petroleum ether/EtOAc 5:1 isocratic), afforded the title compound 3k (112 
mg, 0.34 mmol, 41%) as off-white solid. m.p. 132±134 Ԩ; IR (ATR)/cm-1 3109, 3078, 2921, 2853, 2224, 
1714, 1608, 1569, 1525, 1391; 1H NMR (400 MHz, CDCl3įGG J = 4.9 Hz, J = 1.8 Hz, 1H), 8.28 
(d, J = 9.0 Hz, 2H), 8.20 (d, J = 9.0 Hz, 2H), 7.83 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.11 (dd, J = 7.7 Hz, 
J = 4.9 Hz, 1H), 4.65 (t, J = 6.4 Hz, 2H), 3.70 (t, J = 6.4 Hz, 2H); 13C NMR (101 MHz, CDCl3į
161.8, 152.3, 150.8, 141.0, 135.4, 130.9, 123.7, 119.2, 115.3, 107.9, 64.1, 28.7; LRMS (ES + APCI) m/z: 
calcd. for C15H11N3O4S 329.0; found 330.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C15H12N3O4S 330.0543; found 330.0545. 
3-((3-Cyanopyridin-2-yl)thio)propyl 4-nitrobenzoate (3l). Following General Procedure B, 3-cyano-
pyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) and thietane (308 
 mg, 4.15 mmol) in diisopropyl ether (0.4 M), after purification via flash column chromatography (dry 
loading, petroleum ether/EtOAc 5:1 isocratic), afforded the title compound 3l (48 mg, 0.14 mmol, 17%) 
as a yellow solid. m.p. 123±125 Ԩ; IR (ATR)/cm-1 3113, 3081, 2957, 2933, 2220, 1716, 1607, 1567, 
1519, 1385; 1H NMR (400 MHz, CDCl3įGGJ = 4.9 Hz, J = 1.8 Hz, 1H), 8.34±8.22 (m, 2H), 
8.27±8.22 (m, 2H) 7.80 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.08 (dd, J = 7.7 Hz, 4.9 Hz, 1H), 4.52 (t, J = 
7.0 Hz, 2H), 3.45 (t, J = 7.0 Hz, 2H), 2.26 (app quint, J = 7.0 Hz, 2H); 13C NMR (101 MHz, CDCl3į
164.7, 162.6, 152.2, 150.8, 140.8, 135.7, 130.9, 123.8, 118.8, 115.5, 107.8, 64.6, 28.6, 26.8; LRMS 
(ES + APCI) m/z: calcd. for C16H13N3O4S 343.1; found 344.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ 
calcd. for C16H14N3O4S 344.0705; found 344.0708. 
2-((3-Chloropropyl)thio)nicotinonitrile (4l). Following General Procedure B, with stirring at 25 °C over-
night 3-cyanopyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) and 
thietane (308 mg, 4.15 mmol) in diisopropyl ether (0.4 M), after purification via flash column chroma-
tography (dry loading, petroleum ether/EtOAc 5:1 isocratic), afforded the title compound 4l (100 mg, 
0.47 mmol, 57%) as a yellow oil. IR (ATR)/cm-1 3063, 2955, 2222, 1571, 1551, 1441, 1391; 1H NMR 
(400 MHz, CDCl3įGGJ = 4.9 Hz, J = 1.8 Hz, 1H), 7.79 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.08 
(dd, J = 7.7 Hz, J = 4.9 Hz, 1H), 3.60 (t, J = 7.0 Hz, 2H), 3.42 (t, J = 7.0 Hz, 2H), 2.20 (app quint, J = 7.0 
Hz, 2H); 13C NMR (101 MHz, CDCl3įLRMS 
(ES + APCI) m/z: calcd. for C9H935ClN2S 212.0; found 212.9 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ 
calcd. for C9H1035ClN2S 213.0248; found 213.0248. 
2-((5-Chloropentyl)thio)nicotinonitrile (4m). Following General Procedure B, 3-cyanopyridine N-oxide 
(100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) and thiane (424 mg, 4.15 mmol) in 
diisopropyl ether (0.4 M), after purification via flash column chromatography (dry loading, petroleum 
ether/EtOAc 8:1 isocratic), afforded the title compound 4m (66 mg, 0.28 mmol, 33%) as a yellow solid. 
m.p. 28±30 Ԩ; IR (ATR)/cm-1 3059, 2988, 2949, 2925, 2853, 2224, 1571, 1545, 1391; 1H NMR (400 
MHz, CDCl3įGGJ = 4.9 Hz, J = 1.8 Hz, 1H), 7.79 (dd, J = 7.7 Hz, J = 1.8 Hz, 1H), 7.07 (dd, J = 
 7.7 Hz, J = 4.9 Hz, 1H), 3.55 (t, J = 7.0 Hz, 2H), 3.28 (t, J = 7.0 Hz, 2H), 1.88±1.73 (m, 4H), 1.66±1.57 
(m, 2H); 13C NMR (101 MHz, CDCl3į
26.2; LRMS (ES + APCI) m/z: calcd. for C11H1335ClN2S 240.0; found 241.1 [M+H]+; HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C11H1435ClN2S 241.0566; found 241.0567. 
2-((2-((2-Chloroethyl)thio)ethyl)thio)nicotinonitrile (4n). Following General Procedure B, 3-cyano-
pyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 1.83 mmol) and 1,4-dithiane 
(500 mg, 4.15 mmol) in diisopropyl ether (0.4 M), after purification via flash column chromatography 
(dry loading, petroleum ether/EtOAc 7:1 isocratic), afforded the title compound 4n (78 mg, 0.30 mmol, 
36%) as an off-white solid. m.p. 58±60 Ԩ; IR (ATR)/cm-1 3057, 2964, 2946, 2929, 2222, 1571, 1553, 
1437, 1393; 1H NMR (400 MHz, CDCl3įGGJ = 4.9 Hz, J = 1.8 Hz, 1H), 7.82 (dd, J = 7.7 Hz, J 
= 1.8 Hz, 1H), 7.11 (dd, J = 7.7 Hz, J = 4.9 Hz, 1H), 3.75±3.69 (m, 2H), 3.48±3.42 (m, 2H), 3.04±2.98 
(m, 2H), 2.90±2.85 (m, 2H); 13C NMR (101 MHz, CDCl3į
43.1, 34.0, 31.6, 30.1; LRMS (ES + APCI) m/z: calcd. for C10H1135ClN2S2 258.0; found 259.0 [M+H]+; 
HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C10H1235ClN2S2 259.0130; found 259.0129. 
2-((5-Chloropentan-2-yl)thio)nicotinonitrile and 2-((4-chloropentyl)thio)nicotinonitrile (4o). Following 
General Procedure B, 3-cyanopyridine N-oxide (100 mg, 0.83 mmol), 4-nitrobenzoyl chloride (339 mg, 
1.83 mmol) and 2-methyltetrahydrothiophene (426 mg, 4.15 mmol) in diisopropyl ether (0.4 M), after 
purification via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 isocratic), af-
forded the title compound 4o (90 mg, 0.38 mmol, 45%) as a yellow oil in a 1:1 mixture of regioisomers. 
IR (ATR)/cm-1 3056, 2959, 2925, 2224, 1573, 1551, 1443, 1391; 1H NMR (400 MHz, CDCl3į±
8.54 (m, 2H), 7.80±7.76 (m, 2H), 7.09±7.03 (m, 2H), 4.18±4.01 (m, 2H), 3.57 (t, J = 6.4 Hz, 1H), 3.32±
3.26 (m, 3H), 2.04±1.80 (m, 8H), 1.52 (d, J = 6.4 Hz, 4H), 1.45 (d, J = 6.4 Hz, 2H); 13C NMR (101 MHz, 
CDCl3į
30.1, 29.7, 26.4, 25.5, 21.3 (2 C missing); LRMS (ES + APCI) m/z: calcd. for C11H1335ClN2S 240.0; found 
241.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C11H1435ClN2S 241.0561; found 241.0562. 
 3-Cyanoquinoline N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.35 g, 7.79 mmol) was added portion-
wise to a solution of 3-cyanoquinoline (1.00 g, 6.49 mmol) in CH2Cl2 (17 mL) at 0 °C. Following com-
pletion of addition, the reaction mixture was stirred overnight at room temperature and subsequently 
quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers were 
separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined organic 
extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and concen-
trated under reduced pressure. Further purification via flash column chromatography (dry loading, petro-
leum ether/EtOAc 3:1 isocratic), afforded the title compound as an off-white solid (473 mg, 2.78 mmol, 
43%). m.p. 156±158 °C; IR (ATR)/cm-1 3042, 2936, 2237, 1580, 1495, 1372, 1331, 1229; 1H NMR (500 
MHz, CDCl3įGJ = 8.5 Hz, 1H), 8.60 (s, 1H), 8.05 (s, 1H), 7.98±7.90 (m, 2H), 7.78 (app t, J = 
7.5 Hz, 1H); 13C NMR (101 MHz, DMSO-d6) į129.2, 129.1, 120.2, 
115.1, 107.3; LRMS (ES + APCI) m/z: calcd. for C10H6N2O 170.1; found 171.0 [M+H]+; HRMS (ESI-
TOF) m/z: [M+H]+ calcd. for C10H7N2O 171.0558; found 171.0560. 
2-((4-Chlorobutyl)thio)quinoline-3-carbonitrile (6). Following General Procedure A, 3-Cyanoquinoline 
N-oxide (100 mg, 0.59 mmol) and 4-nitrobenzoyl chloride (241 mg, 1.29 mmol) in THT (0.2 M), after 
purification via flash column chromatography (dry loading, petroleum ether/EtOAc 10:1 isocratic), af-
forded the title compound 6 (102 mg, 0.37 mmol, 63%) as a yellow oil. IR (ATR)/cm-1 3050, 2933, 2860, 
2224, 1614, 1584, 1556, 1333; 1H NMR (500 MHz, CDCl3įV+G J = 8.0 Hz, 1H), 7.82±
7.74 (m, 2H), 7.52 (ddd, J = 8.0 Hz, J = 7.0 Hz, 1.0 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.43 (t, J = 6.5 Hz, 
2H), 2.05±1.93 (m, 4H); 13C NMR (125 MHz, CDCl3į
123.9, 115.9, 106.3, 44.5, 31.7, 29.5, 26.5; LRMS (ES + APCI) m/z: calcd. for C14H1335ClN2S 276.0; 
found 277.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C14H1435ClN2S 277.0566; found 
277.0570. 
3-Chloroquinoline N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.27 g, 7.36 mmol) was added por-
tion-wise to a solution of 3-chloroquinoline (1.00 g, 6.13 mmol) in CH2Cl2 (16 mL) at 0 °C. Following 
 completion of addition, the reaction mixture was stirred overnight at room temperature and subsequently 
quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers were 
separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined organic 
extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and concen-
trated under reduced pressure to afford the title compound as a pale yellow solid (1.04 g, 5.81 mmol, 
95%). m.p. 118±120 °C; IR (ATR)/cm-1 3066, 2921, 2851, 1580, 1556, 1361, 1216; 1H NMR (400 MHz, 
CDCl3įGJ = 8.4 Hz, 1H), 8.51 (d, J = 1.2 Hz, 1H), 7.78 (d, J = 8.4 Hz, 1H), 7.76±7.70 (m, 2H) 
7.69±7.63 (m, 1H); 13C NMR (101 MHz, CDCl3) į
119.9; LRMS (ES + APCI) m/z: calcd. for C9H635ClNO 179.0; found 179.9 [M+H]+; HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C9H735ClNO 179.0132; found 179.0133. 
3-Chloro-2-((4-chlorobutyl)thio)quinoline (7). Following General Procedure A, 3-Chloroquinoline N-ox-
ide (100 mg, 0.56 mmol) and 4-nitrobenzoyl chloride (229 mg, 1.23 mmol) in THT (0.2 M), after purifi-
cation via flash column chromatography (dry loading, petroleum ether/CH2Cl2 2:1 isocratic), afforded the 
title compound 7 (99 mg, 0.35 mmol, 62%) as a yellow oil. IR (ATR)/cm-1 3053, 2914, 2847, 1579, 1523, 
1469, 1383; 1H NMR (500 MHz, CDCl3įV+GJ = 8.5 Hz, 1H), 7.68±7.62 (m, 2H), 7.45 
(app t, J = 7.0 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.38 (t, J = 6.5 Hz, 2H), 2.05±1.94 (m, 4H); 13C NMR 
(125 MHz, CDCl3į.4, 133.9, 129.8, 128.0, 127.2, 126.9, 126.4, 126.1, 44.7, 31.9, 29.6, 26.6; 
LRMS (ES + APCI) m/z: calcd. for C13H1335Cl2NS 285.0; found 285.9 [M+H]+; HRMS (ESI-TOF) m/z: 
[M+H]+ calcd. for C13H1435Cl2NS 286.0224; found 286.0227. 
3-Cyanopyrazine N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.97 g, 11.42 mmol) was added por-
tion-wise to a solution of pyrazine-2-carbonitrile (1.00 g, 9.51 mmol) in CH2Cl2 (25 mL) at 0 °C. Follow-
ing completion of addition, the reaction mixture was stirred overnight at room temperature and subse-
quently quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers 
were separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined or-
ganic extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and 
 concentrated under reduced pressure. Further purification via flash column chromatography (dry loading, 
petroleum ether/EtOAc 3:1 isocratic), afforded the title compound as an off-white solid (240 mg, 1.98 
mmol, 21%). m.p. 140±142 °C; IR (ATR)/cm-1 3059, 3013, 2903, 2200, 1579, 1456, 1415, 1279; 1H NMR 
(500 MHz, CDCl3įGJ = 4.0 Hz, 1H), 8.37 (d, J = 1.5 Hz, 1H), 8.22 (dd, J = 4.0 Hz, J = 1.5 Hz, 
1H); 13C NMR (125 MHz, CDCl3) į, 136.7, 134.2, 113.7; LRMS (ES + APCI) m/z: calcd. 
for C5H3N3O 121.0; found 122.1 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C5H4N3O 121.0271; 
found 121.0270. 
3-((4-Chlorobutyl)thio)pyrazine-2-carbonitrile (8). Following General Procedure A, 3-Cyanopyrazine N-
oxide (100 mg, 0.83 mmol) and 4-nitrobenzoyl chloride (338 mg, 1.82 mmol) in THT (0.2 M), after pu-
rification via flash column chromatography (dry loading, petroleum ether/EtOAc 6:1 isocratic), afforded 
the title compound 8 (105 mg, 0.46 mmol, 56%) as a yellow oil. IR (ATR)/cm-1 3070, 2927, 2864, 2230, 
1514, 1430, 1357, 1196; 1H NMR (500 MHz, CDCl3įGJ = 2.5 Hz, 1H), 8.32 (d, J = 2.5 Hz, 1H), 
3.58 (t, J = 6.5 Hz, 2H), 3.29 (t, J = 6.5 Hz, 2H), 1.98±1.88 (m, 4H); 13C NMR (125 MHz, CDCl3į
161.4, 146.0, 139.6, 128.4, 114.5, 44.3, 31.5, 29.4, 26.4; LRMS (ES + APCI) m/z: calcd. for C9H1035ClN3S 
227.0; found 228.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C9H1135ClN3S 228.0362; found 
228.0366. 
3-Chloropyrazine N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.80 g, 10.50 mmol) was added por-
tion-wise to a solution of 2-chloropyrazine (1.00 g, 8.73 mmol) in CH2Cl2 (23 mL) at 0 °C. Following 
completion of addition, the reaction mixture was stirred overnight at room temperature and subsequently 
quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers were 
separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined organic 
extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and concen-
trated under reduced pressure. Further purification via flash column chromatography (dry loading, petro-
leum ether/EtOAc 5:1 isocratic), afforded the title compound as an off-white solid (970 mg, 7.46 mmol, 
85%). m.p. 97±99 °C; IR (ATR)/cm-1 3053, 3005, 2979, 1582, 1445, 1409, 1272; 1H NMR (500 MHz, 
 CDCl3įGJ = 4.0 Hz, 1H), 8.15 (d, J = 1.5 Hz, 1H), 8.01 (dd, J = 4.0 Hz, J = 1.5 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) įLRMS (ES + APCI) m/z: calcd. for C4H335ClN2O 130.0; 
found 131.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C4H435ClN2O 130.9914; found 130.9915. 
2-Chloro-3-((4-chlorobutyl)thio)pyrazine (9). Following General Procedure A, 3-Chloropyrazine N-oxide 
(100 mg, 0.77 mmol) and 4-nitrobenzoyl chloride (315 mg, 1.69 mmol) in THT (0.2 M), after purification 
via flash column chromatography (dry loading, petroleum ether/CH2Cl2 3:1 isocratic), afforded the ti-
tle compound 9 (98 mg, 0.42 mmol, 54%) as a yellow oil. IR (ATR)/cm-1 3046, 2927, 2866, 1528, 1497, 
1432, 1337, 1143; 1H NMR (500 MHz, CDCl3įGJ = 2.5 Hz, 1H), 8.01 (d, J = 2.5 Hz, 1H), 3.58 
(t, J = 6.5 Hz, 2H), 3.20 (t, J = 6.5 Hz, 2H), 1.99±1.85 (m, 4H); 13C NMR (125 MHz, CDCl3į
146.5, 141.8, 137.9, 44.5, 31.7, 29.6, 26.3 LRMS (ES + APCI) m/z: calcd. for C8H1035Cl2N2S 236.0; found 
236.4 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C8H1135Cl2N2S 237.0020; found 237.0024. 
5-Chloropyrimidine N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.81 g, 10.50 mmol) was added por-
tion-wise to a solution of 5-chloropyrimidine (1.00 g, 8.73 mmol) in CH2Cl2 (23 mL) at 0 °C. Following 
completion of addition, the reaction mixture was stirred overnight at room temperature and subsequently 
quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers were 
separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined organic 
extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and concen-
trated under reduced pressure. Further purification via flash column chromatography (dry loading, petro-
leum ether/EtOAc 3:1 isocratic), afforded the title compound as an off-white solid (874 mg, 6.72 mmol, 
77%). m.p. 108±109 °C; IR (ATR)/cm-1 3026, 3003, 2879, 1569, 1519, 1406, 1249; 1H NMR (500 MHz, 
CDCl3įV+V+V+ 13C NMR (125 MHz, CDCl3) į
130.8; LRMS (ES + APCI) m/z: calcd. for C4H335ClN2O 130.0; found 130.8 [M+H]+; HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C4H435ClN2O 131.0007; found 130.9996. 
5-Chloro-4-((4-chlorobutyl)thio)pyrimidine (10). Following General Procedure A, 5-Chloropyrimidine 
N-oxide (100 mg, 0.77 mmol) and 4-nitrobenzoyl chloride (315 mg, 1.69 mmol) in THT (0.2 M), after 
 purification via flash column chromatography (dry loading, petroleum ether/CH2Cl2 1:1 isocratic), af-
forded the title compound 10 (114 mg, 0.48 mmol, 63%) as a yellow oil. IR (ATR)/cm-1 3040, 2936, 2866, 
1543, 1415, 1370, 1132; 1H NMR (500 MHz, CDCl3įV+V+W J = 6.5 Hz, 
2H), 3.20 (t, J = 6.5 Hz, 2H), 1.99±1.86 (m, 4H); 13C NMR (125 MHz, CDCl3į
128.9, 44.4, 31.7, 29.1, 26.5; LRMS (ES + APCI) m/z: calcd. for C8H1035Cl2N2S 236.0; found 237.0 
[M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C8H1135Cl2N2S 237.0020; found 237.0025. 
2,6-Dichloropyridine N-oxide.18 m-Chloroperoxybenzoic acid (<77%, 1.40 g, 8.10 mmol) was added por-
tion-wise to a solution of 2,6-dichloropyridine (1.00 g, 6.76 mmol) in CH2Cl2 (18 mL) at 0 °C. Following 
completion of addition, the reaction mixture was stirred overnight at room temperature and subsequently 
quenched with a saturated aqueous solution of potassium carbonate (30 mL). The resulting layers were 
separated before the aqueous layer was extracted with chloroform (5 × 40 mL). The combined organic 
extracts were washed with NaHCO3 (50 mL) and brine (50 mL) before being dried, filtered and concen-
trated under reduced pressure. Further purification via flash column chromatography (dry loading, petro-
leum ether/EtOAc 5:1 isocratic), afforded the title compound as an off-white solid (420 mg, 2.58 mmol, 
38%). m.p. 135±137 °C; IR (ATR)/cm-1 3081, 2960, 2866, 1532, 1447, 1365, 1264, 1143; 1H NMR 
(500 MHz, CDCl3įGJ = 8.0 Hz, 2H), 7.12 (t, J = 8.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) į
143.9, 125.2, 124.6; LRMS (ES + APCI) m/z: calcd. for C5H335Cl2NO 163.0; found 164.1 [M+H]+; 
HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C5H435Cl2NO 163.9664; found 163.9662. 
2-((4-Azidobutyl)thio)nicotinonitrile (17). A microwave vial, placed under an inert atmosphere, was 
charged with a solution of 4a (50 mg, 0.22 mmol) in dimethylformamide (DMF) (0.9 mL). To this solu-
tion was added sodium azide (86 mg, 1.33 mmol). The reaction mixture was stirred at 80 °C for 48 hours 
before being cooled to room temperature. A 1:1 mixture of EtOAc/H2O (10 mL) was added, the layers 
separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined organic extracts were 
washed with brine (10 mL), dried over MgSO4, filtered and concentrated under reduced pressure to afford 
the title compound 17 (50 mg, 0.21 mmol, 97%) as a yellow oil. IR (ATR)/cm-1 3057, 2931, 2862, 2224, 
 1573, 1551, 1391; 1H NMR (500 MHz, CDCl3įGGJ = 5.0 Hz, J = 2.0 Hz, 1H), 7.79 (dd, J = 8.0 
Hz, J = 2.0 Hz, 1H), 7.07 (dd, J = 8.0 Hz, J = 5.0 Hz, 1H), 3.33 (t, J = 7.0 Hz, 2H), 3.29 (t, J = 7.0 Hz, 
2H) 1.87±1.80 (m, 2H), 1.79±1.72 (m, 2H); 13C NMR (101 MHz, CDCl3į
115.6, 107.7, 51.1, 29.6, 28.1, 26.6; LRMS (ES + APCI) m/z: calcd. for C10H11N5S 233.1; found 234.0 
[M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C10H12N5S 234.0808; found 234.0809. 
2-((4-Morpholinobutyl)thio)nicotinonitrile (18). To a microwave vial, charged with compound 4a (95 mg, 
PPROZDVDGGHGPRUSKROLQHȝ/PPRO7KHUHDFWLRQPL[WXUHZDVVWLUUHGDWURRPtem-
perature for 48 hours. The solvent was removed under reduced pressure. A 1:1 mixture of EtOAc/H2O 
(10 mL) was added, the layers separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The 
combined organic extracts were washed with brine (10 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure to afford the crude product. Further purification was performed via flash column 
chromatography (petroleum ether 1:1 EtOAc, isocratic) to afford the title compound 18 (38 mg, 0.14 
mmol, 36%) as a yellow oil. IR (ATR)/cm-1 3072, 2934, 2853, 2804, 2222, 1573, 1549, 1391, 1166; 1H 
NMR (500 MHz, CDCl3įGG J = 5.0 Hz, J = 1.5 Hz, 1H), 7.77 (dd, J = 7.5 Hz, J = 1.5 Hz, 1H), 
7.05 (dd, J = 7.5 Hz, J = 5.0 Hz, 1H), 3.70 (t, J = 5.0 Hz, 4H), 3.29 (t, J = 7.5 Hz, 2H), 2.46±2.40 (m, 4H), 
2.37 (t, J = 7.5 Hz, 2H), 1.81±1.73 (m, 2H), 1.69±1.62 (m, 2H); 13C NMR (101 MHz, CDCl3į
152.2, 140.7, 118.5, 115.7, 107.6, 67.1, 58.5, 53.8, 30.2, 27.2, 25.8; LRMS (ES + APCI) m/z: calcd. for 
C14H19N3OS 277.1; found 278.1 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C14H20N3OS 
278.1322; found 278.1323. 
4-((3-Cyanopyridin-2-yl)thio)butyl acetate (19). To a microwave vial, charged with compound 4a (100 
mg, 0.44 mmol) in a solution of DMF (1.8 mL), was added sodium acetate (218 mg, 2.65 mmol). The 
reaction mixture was heated to 80 °C for 48 hours before being allowed to cool to room temperature. A 
1:1 mixture of EtOAc/H2O (10 mL) was added, the layers separated and the aqueous phase extracted with 
EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure to afford the title compound 19 (107 mg, 0.43 mmol, 
 97%) as a yellow oil. IR (ATR)/cm-1 3065, 2946, 2864, 2224, 1731, 1573, 1549, 1391, 1233; 1H NMR 
(400 MHz, CDCl3įGGJ = 4.8 Hz, J = 1.6 Hz, 1H), 7.78 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H), 7.06 
(dd, J = 8.0 Hz, J = 4.8 Hz, 1H), 4.13±4.08 (m, 2H), 3.32±3.28 (m, 2H), 2.05 (s, 3H), 1.84±1.77 (m, 4H); 
13C NMR (101 MHz, CDCl3į
21.1; LRMS (ES + APCI) m/z: calcd. for C12H14N2O2S 250.1; found 251.0 [M+H]+; HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C12H15N2O2S 251.0849; found 251.0850. 
S-(4-((3-Cyanopyridin-2-yl)thio)butyl) ethanethioate (20). To a microwave vial, charged with compound 
4a (50 mg, 0.22 mmol) in a solution of DMF (1.1 mL), was added potassium thioacetate (152 mg, 1.32 
mmol) and potassium iodide (8.2 mg, 0.04 mmol). The reaction mixture was heated to 80 °C for 48 hours 
before being allowed to cool to room temperature. A 1:1 mixture of EtOAc/H2O (10 mL) was added, the 
layers separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined organic extracts 
were washed with brine (10 mL), dried over MgSO4, filtered and concentrated under reduced pressure to 
afford the title compound 21 (56 mg, 0.21 mmol, 96%) as a yellow oil. IR (ATR)/cm-1 3063, 2923, 2851, 
2222, 1683, 1571, 1549, 1391, 1138; 1H NMR (400 MHz, CDCl3įGGJ = 4.8 Hz, J = 1.6 Hz, 1H), 
7.78 (dd, J = 7.6 Hz, J = 1.6 Hz, 1H), 7.06 (dd, J = 7.6 Hz, J = 4.8 Hz, 1H), 3.27 (t, J = 7.2 Hz, 2H), 2.91 
(t, J = 7.2 Hz, 2H), 2.32 (s, 3H), 1.85±1.69 (m, 4H); 13C NMR (101 MHz, CDCl3į
140.7, 118.6, 115.7, 107.6, 30.8, 29.6, 28.8, 28.6, 28.4; LRMS (ES + APCI) m/z: calcd. for C12H14N2OS2 
266.1; found 267.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C12H15N2OS2 267.0620; found 
267.0621. 
2-((4-((4-Methoxyphenyl)thio)butyl)thio)nicotinonitrile (21). To a microwave vial, charged with com-
pound 4a (50 mg, 0.22 mmol) in a solution of DMF (1.1 mL), was added 4-methoxybenzenethiol (63 mg, 
0.44 mmol) and caesium carbonate (216 mg, 0.66 mmol). The reaction mixture was heated to 80 °C for 
48 hours before being allowed to cool to room temperature. A 1:1 mixture of EtOAc/H2O (10 mL) was 
added, the layers separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined 
organic extracts were washed with brine (10 mL), dried over MgSO4, filtered and concentrated under 
 reduced pressure to afford the title compound 23 (25 mg, 0.08 mmol, 34%) as an off-white solid. m.p. 
38±40 °C; IR (ATR)/cm-1 3066, 2949, 2830, 2220, 1571, 1553, 1493, 1395, 1235; 1H NMR (400 MHz, 
CDCl3įGGJ = 5.2 Hz, J = 1.6 Hz, 1H), 7.77 (dd, J = 7.6 Hz, J = 1.6 Hz, 1H), 7.34 (d, J = 8.8 Hz, 
2H), 7.05 (dd, J = 7.6 Hz, J = 5.2 Hz, 1H), 6.83, (d, J = 8.8 Hz, 2H), 3.80 (s, 3H), 3.25 (t, J = 7.2 Hz, 2H), 
2.85 (t, J = 7.2 Hz, 2H), 1.90±1.81 (m, 2H), 1.77±1.68 (m, 2H); 13C NMR (101 MHz, CDCl3į
159.1, 152.2, 140.7, 133.5, 126.4, 118.5, 115.7, 114.7, 107.6, 55.5, 35.5, 29.8, 28.4, 28.1; LRMS (ES + 
APCI) m/z: calcd. for C17H18N2OS2 330.1; found 331.0 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. 
for C17H19N2OS2 331.0939; found 331.0936. 
Diethyl (4-((3-cyanopyridin-2-yl)thio)butyl)phosphonate (22). To a microwave vial, charged with com-
pound 4a (50 mg, 0.22 mmol), was added triethyl phosphite (484 mg, 2.92 mmol). The reaction mixture 
was heated to 160 °C for 48 hours before being allowed to cool to room temperature. A 1:1 mixture of 
EtOAc/H2O (10 mL) was added, the layers separated and the aqueous phase extracted with EtOAc (3 × 
10 mL). The combined organic extracts were washed with brine (10 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. Further purification via flash column chromatography (dry loading, 
petroleum ether/EtOAc 3:1 isocratic), afforded the title compound 24 (23 mg, 0.07 mmol, 32%) as an 
orange oil. IR (ATR)/cm-1 3047, 2931, 2867, 2222, 1573, 1551, 1391, 1231, 1017, 956; 1H NMR 
(500 MHz, CDCl3įGJ = 4.0 Hz, 1H), 7.77 (d, J = 7.5 Hz, 1H), 7.05 (dd, J = 7.5 Hz, J = 4.0 Hz, 
1H), 4.18±4.02 (m, 4H), 3.27 (t, J = 6.0 Hz, 2H), 1.88±1.72 (m, 6H), 1.32 (t, J = 6.0 Hz, 6H); 13C NMR 
(101 MHz, CDCl3į  163.1, 152.2 (d, JPC = 18.5 Hz, 1C), 140.7 (d, JPC = 9.0 Hz, 1C), 118.6, 115.6, 107.6, 
62.0±60.4 (m, 2C), 31.2±28.3 (m, 3C), 22.3 (d, JPC = 107.5 Hz 1C), 16.6 (d, JPC = 66. 8 Hz, 2C); 31P NMR 
(202 MHz, CDCl3į±28.5 (m, 1P); LRMS (ES + APCI) m/z: calcd. for C14H21N2O3PS 328.1; found 
328.7 [M+H]+; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C14H22N2O3PS 329.1089; found 329.1087. 
2-((4-Cyanobutyl)thio)nicotinonitrile (23). A microwave vial, placed under an inert atmosphere, was 
charged with a solution of 4a (50 mg, 0.22 mmol) in DMF (0.8 mL). To this solution was added potassium 
cyanide (29 mg, 0.44 mmol) and potassium iodide (2.2 mg, 0.01 mmol). The reaction mixture was stirred 
 at room temperature for 18 hours. A 1:1 mixture of EtOAc/H2O (10 mL) was added, the layers separated 
and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed 
with brine (10 mL), dried over MgSO4, filtered and concentrated under reduced pressure to afford the title 
compound 25 (42 mg, 0.19 mmol, 88%) as a yellow oil. IR (ATR)/cm-1 3055, 2936, 2856, 2243, 2222, 
1571, 1551, 1391; 1H NMR (400 MHz, CDCl3įGG J = 4.8 Hz, J = 1.6 Hz, 1H), 7.79 (dd, J = 7.6 
Hz, J = 1.6 Hz, 1H), 7.08 (dd, J = 7.6 Hz, J = 4.8 Hz, 1H), 3.30 (t, J = 6.8 Hz, 2H), 2.42 (t, J = 6.8 Hz, 2H), 
1.95±1.78 (m, 4H); 13C NMR (101 MHz, CDCl3į
28.4, 24.5, 16.9; LRMS (ES + APCI) m/z: calcd. for C11H11N3S 217.1; found 218.0 [M+H]+; HRMS (ESI-
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